Sinovac Biotech Ltd.
Stock Forecast, Prediction & Price Target
Sinovac Biotech Ltd. Financial Estimates
Sinovac Biotech Ltd. Revenue Estimates
Sinovac Biotech Ltd. EBITDA Estimates
Sinovac Biotech Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $19.37B N/A | $1.49B -92.29% | $448.26M -69.97% | Avg: $742.63M Low: $742.63M High: $742.63M avg. 65.66% | |||
Net Income
% change YoY
| $8.46B N/A | $113.86M -98.65% | $-99.91M -187.75% | Avg: $-11.95M Low: $-12.94M High: $-10.95M avg. 88.03% | |||
EBITDA
% change YoY
| $17.65B N/A | $188.31M -98.93% | $-6.02M -103.20% | Avg: $299.13M Low: $299.13M High: $299.13M avg. 5061.66% | |||
EPS
% change YoY
| $85.2 N/A | $1.08 -98.73% | -$1.06 -198.14% | Avg: -$0.12 Low: -$0.13 High: -$0.11 avg. 88.67% | |||
Operating Expenses
% change YoY
| $748.44M N/A | $1.26B 69.57% | $813.47M -35.90% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Sinovac Biotech Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 88.03% in 2025-2025.
We have gathered data from 4 analysts. Their low estimate is -12.94M, average is -11.95M and high is -10.95M.
What is Sinovac Biotech Ltd. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 65.66% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $742.63M, average is $742.63M and high is $742.63M.
What is Sinovac Biotech Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 88.67% in 2025-2025.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.13, average is -$0.12 and high is $-0.11.